Imiquimod

Imiquimod is primarily used in dermatology for treating:

• Actinic Keratosis: A precancerous skin condition.
• Superficial Basal Cell Carcinoma: A common form of skin cancer.
• Anogenital Warts: Caused by human papillomavirus infection.
• Other Dermatoses: Off-label uses include treatment for various benign and malignant skin conditions due to its immunomodulatory properties.

The biological activity of Imiquimod is primarily characterized by its immunomodulatory effects. It stimulates both innate and adaptive immune responses, leading to increased infiltration of inflammatory cells at the site of application. This immune activation results in apoptosis of diseased tissue and is crucial for its therapeutic effects against skin lesions. Additionally, Imiquimod has been shown to enhance acquired immunity by activating plasmacytoid dendritic cells, which produce type I interferons essential for modulating immune responses.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.